2026 Q3 Portfolio Activity
In 2026 Q3, Novo Holdings A/S maintained a portfolio of 28 distinct positions. The most significant new addition was OBSIDIAN THERAPEUTICS INC, now representing 2.88% of the total fund value. They heavily accumulated shares in BROOKFIELD CORP, increasing the position by 27.7%. The fund also reduced its exposure to MAPLIGHT THERAPEUTICS INC by 43.4%.
Position History
hover any row below to update
Loading…
Total Positions
28
Quarter
2026 Q3
Top Holding
EWTX (14.6%)
Top 10 Concentration
73.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-28 of 28
Novo Holdings A/S Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 14.58% | 12.62% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
5,350,000 | $217,210,000 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ASML
ASML HOLDING N ...
|
Technology | 11.55% | 10.97% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
94,946 | $172,010,820 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BN
BROOKFIELD CORP
|
Financial Services | 10.93% | 8.68% |
#3
1
Prev: #4
|
7.5 |
—
|
968,790 | 27.7% |
P
S
|
4,465,035 | $162,795,176 | 2023 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COAG
HEMAB THERAPEUT...
|
Healthcare | 8.65% | 8.92% |
#4
1
Prev: #3
|
5.0 |
—
|
no change | no change |
P
S
|
4,180,550 | $128,928,162 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 6.60% | 7.42% |
#5
2
Prev: #7
|
3.6 |
—
|
-434,098 | -11.2% |
P
S
|
3,449,191 | $98,267,452 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 6.46% | 7.65% |
#6
Prev: #6
|
3.6 |
—
|
no change | no change |
P
S
|
1,125,000 | $96,165,000 | 2019 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRM
SALESFORCE INC
|
Technology | 6.06% | 3.58% |
#7
1
Prev: #8
|
3.4 |
—
|
no change | no change |
P
S
|
393,187 | $90,263,940 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 3.08% | 2.95% |
#8
2
Prev: #10
|
2.2 |
—
|
no change | no change |
P
S
|
1,000,000 | $45,840,000 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FDMT
4D MOLECULAR TH...
|
Healthcare | 2.88% | 2.51% |
#9
6
Prev: #15
|
1.7 |
—
|
-249,178 | -7.7% |
P
S
|
3,000,000 | $42,930,000 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
OBX
OBSIDIAN THERAP...
|
Healthcare | 2.88% | — |
#10
Prev: #—
|
4.7 |
—
|
3,123,992 | — |
NEW
|
3,123,992 | $42,892,410 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 2.71% | 2.70% |
#11
3
Prev: #14
|
1.6 |
—
|
-90,000 | -11.2% |
P
S
|
710,000 | $40,399,000 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
FND
FLOOR & DECOR H...
|
Consumer Cyclical | 2.45% | 2.75% |
#12
1
Prev: #13
|
2.0 |
—
|
no change | no change |
P
S
|
797,000 | $36,510,570 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 2.42% | 2.28% |
#13
3
Prev: #16
|
1.5 |
—
|
-385,000 | -18.0% |
P
S
|
1,750,000 | $36,032,500 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVBP
ARRIVENT BIOPHA...
|
Healthcare | 2.39% | 3.03% |
#14
5
Prev: #9
|
1.0 |
—
|
-325,000 | -21.7% |
P
S
|
1,175,000 | $35,579,000 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 2.18% | 0.75% |
#15
8
Prev: #23
|
3.9 |
—
|
163,702 | 135.6% |
P
S
|
284,425 | $32,464,270 | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHVS
PHARVARIS N V
|
Healthcare | 2.17% | 2.81% |
#16
4
Prev: #12
|
0.9 |
—
|
-380,574 | -27.2% |
P
S
|
1,019,426 | $32,336,193 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CLDX
CELLDEX THERAPE...
|
Healthcare | 2.07% | 2.21% |
#17
Prev: #17
|
1.3 |
—
|
-75,000 | -7.3% |
P
S
|
950,000 | $30,789,500 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BABA
ALIBABA GROUP H...
|
Consumer Cyclical | 1.86% | 1.43% |
#18
2
Prev: #20
|
1.7 |
—
|
no change | no change |
P
S
|
257,327 | $27,672,946 | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.63% | 1.70% |
#19
Prev: #19
|
3.2 |
—
|
166,667 | 34.3% |
P
S
|
652,105 | $24,251,785 | 2014 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 1.49% | — |
#20
Prev: #—
|
4.1 |
—
|
460,002 | — |
NEW
|
460,002 | $22,227,297 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.49% | 1.24% |
#21
Prev: #21
|
3.1 |
—
|
415,770 | 43.3% |
P
S
|
1,376,164 | $22,170,002 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 1.43% | 7.67% |
#22
17
Prev: #5
|
0.6 |
—
|
-1,600,000 | -43.4% |
P
S
|
2,086,622 | $21,262,678 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 0.63% | — |
#23
Prev: #—
|
3.8 |
—
|
704,013 | — |
NEW
|
704,013 | $9,447,854 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 0.62% | 1.80% |
#24
6
Prev: #18
|
2.2 |
—
|
150,000 | 13.6% |
P
S
|
1,250,000 | $9,237,500 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBOT
BRIDGEBIO ONCOL...
|
Healthcare | 0.62% | 1.00% |
#25
3
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
2,250,000 | $9,225,000 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MQ
MARQETA INC
|
Technology | 0.13% | 0.42% |
#26
2
Prev: #24
|
0.1 |
—
|
-331,169 | -75.0% |
P
S
|
110,389 | $1,876,061 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LNZA
LANZATECH GLOBA...
|
Industrials | 0.06% | 0.06% |
#27
2
Prev: #25
|
1.0 |
—
|
no change | no change |
P
S
|
158,148 | $903,025 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.00% | 2.87% |
Sold All 😨
(Was: #11) |
0.0 |
—
|
-1,320,000 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-28 of 28 holdings